Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Cell Genesys (CEGE)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: CEGE
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
Developments for Parkinson's Disease Ignite Investor Enthusiasm
Nov 16
•
Michael Becker
•
4 Comments
Transformative Times for BioSante Pharmaceuticals
Oct 21
•
M. E. Garza
•
4 Comments
La Jolla Is Too Much of a Gamble Right Now
Sep 2
•
VFC's Stock House
•
Comment!
Dealmaking Sweeps the Biotech Sector
Jul 5
•
The Burrill Report
•
Comment!
Cell Genesys: BioSante Sees Something Other than Cash
Jul 1
•
EP Vantage
•
Comment!
Closing Update for Tuesday June 30
Jun 30
•
Midnight Trader
•
Comment!
4 Small Cap Stock Briefs
Jun 24
•
VFC's Stock House
•
3 Comments
Five Biopharma Companies Drop on Negative Drug News
Aug 28, 2008
•
Mike Huckman
•
1 Comment
Six Significant Gene Therapy Stocks
May 13, 2008
•
Stockerblog
•
2 Comments
Antigenics, Dendreon and Cell Genesys Find Hope in Overseas Treatment Approvals
Apr 11, 2008
•
Michael Shulman
•
6 Comments
Russian Roulette Pays Off for Antigenics
Apr 9, 2008
•
Mike Huckman
•
5 Comments
Which Has a Better Risk/Reward Ratio - Citigroup or Cell Genesys?
Apr 4, 2008
•
Michael Shulman
•
11 Comments
Amgen: Boxed In
Jan 7, 2008
•
Michael Shulman
•
Comment!
Cell Genesys Searches for Prostate Cancer Cure
Dec 23, 2007
•
Jeff Bishop
•
Comment!
Cell Genesys’ GVAX: A Multi-Trick Pony
Jul 30, 2007
•
Ohad Hammer
•
8 Comments
Cancer Stocks: Tracking the Market
Jul 9, 2007
•
Alan Brochstein
•
Comment!
Cancer Stocks: The Bleeding Slows
Jul 2, 2007
•
Alan Brochstein
•
Comment!
Cancer Stocks Hammered Once Again
Jun 26, 2007
•
Alan Brochstein
•
7 Comments
Cancer Stocks Slide Again
Jun 18, 2007
•
Alan Brochstein
•
1 Comment
Cancer Stocks Plunge Following ASCO Meeting
Jun 11, 2007
•
Alan Brochstein
•
3 Comments
Cell Genesys Should Not Be Trading In Tandem With Dendreon
Jun 6, 2007
•
Steven T. Gold
•
Comment!
Cancer Stocks Soar With Annual ASCO Meeting
Jun 4, 2007
•
Alan Brochstein
•
1 Comment
Cancer Stocks on the Go: Winners and Losers
May 29, 2007
•
Alan Brochstein
•
3 Comments
Cell Genesys: The Promise of GVAX
May 7, 2007
•
Ohad Hammer
•
1 Comment
7 Companies Searching to Treat or Cure Parkinson's
Apr 25, 2007
•
Stockerblog
•
1 Comment
Biotech Day In Review: Genentech Beats Estimates Slightly
Apr 12, 2007
•
Centient Biotech Investor
•
1 Comment
Russell 3000's Best and Worst Stocks, Week and Year to Date
Apr 8, 2007
•
TickerSense
•
Comment!
Biotech Day In Review: Cell Genesys Climbs On GVAX Results
Apr 4, 2007
•
Centient Biotech Investor
•
Comment!
Biotech Week In Review: Barron’s Touts Alzheimers Drugs From Wyeth
Apr 2, 2007
•
Centient Biotech Investor
•
1 Comment
Will Dendreon's Cancer Vaccine Win Final Approval?
Mar 31, 2007
•
Centient Biotech Investor
•
Comment!
Biotech Day in Review: Allergan Expands Obesity Franchise
Feb 23, 2007
•
Centient Biotech Investor
•
Comment!
Renaissance Technologies: "Black-Box" Hedge Fund Discloses New Positions
Feb 13, 2007
•
Lon Juricic
•
Comment!
Biotech Stocks Day-In-Review: Amgen Rises On Speculation Over Patent Suit
Jan 23, 2007
•
Centient Biotech Investor
•
1 Comment